Amy E. Baxter
- Virology top 1%
- HIV Research and Treatment 12
- Immunology top 5%
- Immune Cell Function and Interaction 18
- T-cell and B-cell Immunology 8
- Immunotherapy and Immune Responses 3
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 4
-
- CAR-T cell therapy research 6
- Emergency Medicine top 10%
- HIV-related health complications and treatments 2
-
- Cytomegalovirus and herpesvirus research 3
- Co-authors
- Daniel E. KaufmannJean‐Pierre RoutyNathalie BrassardRémi FromentinNicolas ChomontAndrés FinziJulia NiesslMarta Massanella
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Amy E. Baxter
26 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 83
- Virology 722
- Immunology 749
- Infectious Diseases 462
- Oncology 206
- Emergency Medicine 73
Countries citing papers authored by Amy E. Baxter
This map shows the geographic impact of Amy E. Baxter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Baxter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Baxter more than expected).
Fields of papers citing papers by Amy E. Baxter
This network shows the impact of papers produced by Amy E. Baxter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Baxter. The network helps show where Amy E. Baxter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amy E. Baxter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 11 | |
| 2 | 2024 | 47 | |
| 3 | 2023 | 33 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 42 | |
| 6 | 2022 | 13 | |
| 7 | 2022 | 119 | |
| 8 | 2021 | 35 | |
| 9 | 2021 | 41 | |
| 10 | 2020 | 99 | |
| 11 | 2020 | 29 | |
| 12 | 2019 | 151 | |
| 13 | 2018 | 65 | |
| 14 | 2018 | 5 | |
| 15 | 2017 | 9 | |
| 16 | 2017 | 43 | |
| 17 | 2017 | 193 | |
| 18 | 2014 | 136 | |
| 19 | Phagocytic uptake of transmitted/founder virus-infected CD4+T cells enhances macrophage infection | 2012 | 1 |
| 20 | 1996 | 7 |
About Amy E. Baxter
Amy E. Baxter is a scholar working on Virology, Immunology and Oncology, having authored 26 papers that have together received 1.5k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (18 papers), HIV Research and Treatment (12 papers), T-cell and B-cell Immunology (8 papers), CAR-T cell therapy research (6 papers), HIV/AIDS drug development and treatment (4 papers), Immunotherapy and Immune Responses (3 papers), Cytomegalovirus and herpesvirus research (3 papers) and HIV-related health complications and treatments (2 papers). The work is most often cited by research in Virology (722 citations), Immunology (749 citations) and Infectious Diseases (462 citations). Amy E. Baxter has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Daniel E. Kaufmann, Jean‐Pierre Routy, Nathalie Brassard, Rémi Fromentin, Nicolas Chomont, Andrés Finzi, Julia Niessl, Marta Massanella, Una O’Doherty and Filippos Porichis. Their work appears in journals such as Nature Communications, Cell Reports, Cell Host & Microbe, Science Immunology and EBioMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.